NCT06348459 Registry of Catheter Intervention in Pulmonary Embolism
| NCT ID | NCT06348459 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital San Carlos, Madrid |
| Condition | Pulmonary Embolism |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2018-09-18 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2018-09-18 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Multicenter longitudinal observational ambispective (retrospective cases from 2014 and prospective from 2018 onwards) cohort study. The registry recruits a series of consecutive patients admitted for moderate-high risk or high-risk pulmonary embolism (according to 2019 European Society of Cardiology guidelines) treated invasively. This study aims to describe the acute management of the safety and effectiveness of different percutaneous interventions for acute pulmonary embolism.
Eligibility Criteria
Inclusion Criteria: * adult patients (aged 18 years old or older) * confirmed diagnosis of acute PE (on computed tomography or echocardiogram plus pulmonary angiography) * high-risk PE or intermediate-high risk according to ESC risk stratification in the 2019 guidelines (briefly, elevated cardiac biomarkers \[troponin or N-terminal pro-B-type natriuretic peptide\], and right ventricle to left ventricle ratio \> 0.9 \[on computed tomography or echocardiogram\], and PE severity index III to IV or simplified PE severity index=1 * eligibility for catheter-directed intervention Exclusion Criteria: * unconfirmed diagnosis of PE * undefined risk stratification, and * PE with uncertain chronology or beyond seven days of symptom initiation.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06348459 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Embolism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06348459 currently recruiting?
Yes, NCT06348459 is actively recruiting participants. Contact the research team at salinas.pablo@gmail.com for enrollment information.
Where is the NCT06348459 trial being conducted?
This trial is being conducted at Madrid, Spain.
Who is sponsoring the NCT06348459 clinical trial?
NCT06348459 is sponsored by Hospital San Carlos, Madrid. The trial plans to enroll 300 participants.